Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.540EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.540EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.540ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.540ENiu-ECACGTTAACAATATTGCAGC20402639126372R-18330.5China
B.1.487EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.487EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.487ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.487ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.487EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.487EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.487ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.487ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.118EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.118EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.118ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.118ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.118EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.118EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.118ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.118ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.3.4 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.3.4 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.3.4 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.3.4 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.3.4 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.3.4 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.3.4 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.3.4 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.391EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-1649.2South Korea
B.1.1.391EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
B.1.1.391ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
B.1.1.391ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
B.1.1.391EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
B.1.1.391EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
B.1.1.391ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.1.391ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.393EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.393EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.393ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.393ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.393EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.393EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.393ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.393ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.432EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.432EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.432ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.432ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.432EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.432EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used